EMV Stock Overview
Engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
EMVision Medical Devices Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.88 |
| 52 Week High | AU$2.73 |
| 52 Week Low | AU$1.45 |
| Beta | 1.4 |
| 11 Month Change | -8.29% |
| 3 Month Change | -9.62% |
| 1 Year Change | 18.61% |
| 33 Year Change | -34.49% |
| 5 Year Change | 150.67% |
| Change since IPO | 516.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| EMV | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -2.8% | -0.4% | 0.9% |
| 1Y | 18.6% | 13.5% | 17.7% |
Return vs Industry: EMV exceeded the Australian Medical Equipment industry which returned 13.5% over the past year.
Return vs Market: EMV matched the Australian Market which returned 17.7% over the past year.
Price Volatility
| EMV volatility | |
|---|---|
| EMV Average Weekly Movement | 6.2% |
| Medical Equipment Industry Average Movement | 9.2% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: EMV has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: EMV's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Scott Kirkland | www.emvision.com.au |
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.
EMVision Medical Devices Ltd Fundamentals Summary
| EMV fundamental statistics | |
|---|---|
| Market cap | AU$161.20m |
| Earnings (TTM) | -AU$2.73m |
| Revenue (TTM) | AU$11.22m |
14.4x
P/S Ratio-59.1x
P/E RatioIs EMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMV income statement (TTM) | |
|---|---|
| Revenue | AU$11.22m |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$11.22m |
| Other Expenses | AU$13.95m |
| Earnings | -AU$2.73m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.032 |
| Gross Margin | 100.00% |
| Net Profit Margin | -24.33% |
| Debt/Equity Ratio | 14.0% |
How did EMV perform over the long term?
See historical performance and comparison